Marine Perriguey

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Mass Spectrometry

Hodgkin Lymphoma

Patient Reported

Top Venues

Neurology(R) neuroimmunology & neuroinflammation

This page only lists publications with an associated author ORCID identifier.

Publications

Lisa Graille-Avy, Clemence Boutiere, Camille Rigollet, Marine Perriguey, Audrey Rico, Sarah Demortiere, Pierre Durozard, Frederic Hilezian, Frederic Vely, Pierre Bertault-Peres, Jean Pelletier, Sandra Vukusic, Bertrand Audoin
Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With Multiple Sclerosis. Neurology(R) neuroimmunology & neuroinflammation 11 (3) (2024)
Lisa Graille-Avy, Clemence Boutiere, Camille Rigollet, Marine Perriguey, Audrey Rico, Sarah Demortiere, Pierre Durozard, Frederic Hilezian, Frederic Vely, Pierre Bertault-Peres, Jean Pelletier, Sandra Vukusic, Bertrand Audoin
Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With Multiple Sclerosis. Neurology(R) neuroimmunology & neuroinflammation 11 (3) (2024)
Lisa Graille-Avy, Clemence Boutiere, Camille Rigollet, Marine Perriguey, Audrey Rico, Sarah Demortiere, Pierre Durozard, Frederic Hilezian, Frederic Vely, Pierre Bertault-Peres, Jean Pelletier, Sandra Vukusic, Bertrand Audoin
Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With Multiple Sclerosis. Neurology(R) neuroimmunology & neuroinflammation 11 (3) (2024)
Lisa Graille-Avy, Clemence Boutiere, Camille Rigollet, Marine Perriguey, Audrey Rico, Sarah Demortiere, Pierre Durozard, Frederic Hilezian, Frederic Vely, Pierre Bertault-Peres, Jean Pelletier, Sandra Vukusic, Bertrand Audoin
Effect of Prior Treatment With Fingolimod on Early and Late Response to Rituximab/Ocrelizumab in Patients With Multiple Sclerosis. Neurology(R) neuroimmunology & neuroinflammation 11 (3) (2024)
Roxane Claverie, Marine Perriguey, Audrey Rico, Clemence Boutiere, Sarah Demortiere, Pierre Durozard, Frederic Hilezian, Clea Dubrou, Frederic Vely, Jean Pelletier, Bertrand Audoin, Sandra Vukusic
Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis: Time to Rethink Dosing? Neurology(R) neuroimmunology & neuroinflammation 10 (5) (2023)